Nanjing Vishee Medical Technology Co Ltd. Stock Analysis 688580.SS

Nanjing Vishee Medical Technology Co., Ltd. engages in the research and development, production, and sales of rehabilitation medical devices. The company is headquartered in Nanjing, Jiangsu and currently employs 635 full-time employees. The company went IPO on 2020-07-21. The firm's products primarily include magnetic stimulation products such as transcranial magnetic stimulation (TMS) devices and pelvic floor magnetic stimulation (PEFS) devices, electrical stimulation products such as the VisheeNEO and MyOnyx biofeedback devices, electrophysiological products such as group biofeedback devices and neonatal electroencephalography (EEG) devices, laser and radiofrequency products such as high-frequency electrocautery devices and Nd:YAG frequency-doubling picosecond laser therapy, rehabilitation robots, consumables and accessories such as vaginal and rectal electrodes, as well as other products such as software for treating cognitive impairment.